102 related articles for article (PubMed ID: 9395142)
1. Single-antibody in situ enzyme immunoassay for infectivity titration of hepatitis A virus.
Borovec S; Uren E
J Virol Methods; 1997 Oct; 68(1):81-7. PubMed ID: 9395142
[TBL] [Abstract][Full Text] [Related]
2. In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203).
Villar LM; Amado LA; Gaspar AM
Braz J Med Biol Res; 2004 Jul; 37(7):1023-7. PubMed ID: 15264009
[TBL] [Abstract][Full Text] [Related]
3. A novel cytopathic microtitre plate assay for hepatitis A virus and anti-hepatitis A neutralizing antibodies.
Beales LP; Wood DJ; Minor PD; Saldanha JA
J Virol Methods; 1996 May; 59(1-2):147-54. PubMed ID: 8793842
[TBL] [Abstract][Full Text] [Related]
4. Infectivity titration of the fast-replicating and cytopathic hepatitis A virus strain HM175A.2 by an in situ enzyme immunoassay.
Yap KL; Lam SK
J Virol Methods; 1994 Apr; 47(1-2):217-26. PubMed ID: 8051228
[TBL] [Abstract][Full Text] [Related]
5. [Study of human and simian hepatitis A virus isolated by an immunoenzyme method using polyclonal and monoclonal antibodies].
Karetnyĭ IuV; Andzhaparidze AG; Orlova TM; Balaian MS
Vopr Virusol; 1989; 34(1):50-3. PubMed ID: 2543140
[TBL] [Abstract][Full Text] [Related]
6. Recombinant hepatitis A virus antigen: improved production and utility in diagnostic immunoassays.
LaBrecque FD; LaBrecque DR; Klinzman D; Perlman S; Cederna JB; Winokur PL; Han JQ; Stapleton JT
J Clin Microbiol; 1998 Jul; 36(7):2014-8. PubMed ID: 9650953
[TBL] [Abstract][Full Text] [Related]
7. Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine.
Binn LN; MacArthy PO; Marchwicki RH; Sjogren MH; Hoke CH; Burge JR; D'Hondt E
Vaccine; 1992; 10 Suppl 1():S102-5. PubMed ID: 1335636
[TBL] [Abstract][Full Text] [Related]
8. Quantification of infectious duck hepatitis B virus by radioimmunofocus assay.
Anderson DA; Grgacic EV; Luscombe CA; Gu X; Dixon R
J Med Virol; 1997 Aug; 52(4):354-61. PubMed ID: 9260680
[TBL] [Abstract][Full Text] [Related]
9. Evidence of hepatitis A virus circulation in central Argentina: seroprevalence and environmental surveillance.
Yanez LA; Lucero NS; Barril PA; Díaz Mdel P; Tenaglia MM; Spinsanti LI; Nates SV; Isa MB; Ré VE
J Clin Virol; 2014 Jan; 59(1):38-43. PubMed ID: 24332411
[TBL] [Abstract][Full Text] [Related]
10. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal antibodies in human hepatitis A virus immunoenzyme diagnosis].
Razumov IA; Tumanov IuV; Kazachinskaia EI; Tiunnikov GI; Loktev VB
Vestn Ross Akad Med Nauk; 1998; (3):9-13. PubMed ID: 9608269
[TBL] [Abstract][Full Text] [Related]
12. [Molecular detection and sequence analysis of hepatitis A virus (HAV) in two outbreaks in 2004 in North East Hungary].
Reuter G; Juhász A; Kosztolányi L; Lefler E
Orv Hetil; 2005 Oct; 146(44):2257-62. PubMed ID: 16302357
[TBL] [Abstract][Full Text] [Related]
13. [In situ enzyme immunoassay for detection of hepatitis A virus].
Hou Z; Yan J; Long R
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):362-4. PubMed ID: 12759978
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis A-vaccines: a comparison between three methods of antigen determination.
Burkhardt F; Glück R; Finkel-Jimenez B; Brantschen S
Dev Biol Stand; 1996; 86():129-35. PubMed ID: 8785942
[No Abstract] [Full Text] [Related]
15. A nitrocellulose-enzyme immunoassay method for the detection of hepatitis A virus.
Nadala EC; Loh PC
J Virol Methods; 1990 May; 28(2):155-63. PubMed ID: 2164523
[No Abstract] [Full Text] [Related]
16. Development of a peptide ELISA to discriminate vaccine-induced immunity from natural infection of hepatitis A virus in a phase IV study.
Ye C; Luo J; Wang X; Xi J; Pan Y; Chen J; Yang X; Li G; Sun Q; Yang J
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2165-2170. PubMed ID: 28631170
[TBL] [Abstract][Full Text] [Related]
17. Sensitive assays for hepatitis A antibodies.
Miller WJ; Clark W; Hurni W; Kuter B; Schofield T; Nalin D
J Med Virol; 1993 Nov; 41(3):201-4. PubMed ID: 8263501
[TBL] [Abstract][Full Text] [Related]
18. Analysis of immunoassays to detect antibodies to hepatitis A virus (anti-HAV) and anti-HAV immunoglobulin M.
Hess G; Faatz E; Melchior W; Bayer H
J Virol Methods; 1995 Feb; 51(2-3):221-8. PubMed ID: 7738142
[TBL] [Abstract][Full Text] [Related]
19. Primary isolation of a Brazilian strain of hepatitis A virus (HAF-203) and growth in a primate cell line (FRhK-4).
Gaspar AM; Vitral CL; Yoshida CF; Schatzmayr HG
Braz J Med Biol Res; 1992; 25(7):697-705. PubMed ID: 1342600
[TBL] [Abstract][Full Text] [Related]
20. Infrared fluorescent immunofocus assay (IR-FIFA) for the quantitation of non-cytopathic and minimally cytopathic viruses.
Counihan NA; Daniel LM; Chojnacki J; Anderson DA
J Virol Methods; 2006 Apr; 133(1):62-9. PubMed ID: 16300833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
